Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 26Novo Nordisk

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN ASPART; INSULIN DEGLUDEC

Brand Name : RYZODEG 70/30

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 90 UNITS/3ML;210 UNITS/3ML (30 UNITS/ML;70 UNITS/ML)

Packaging :

Approval Date :

Application Number : 203313

Regulatory Info :

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN DEGLUDEC

Brand Name : TRESIBA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 203314

Regulatory Info :

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN DEGLUDEC

Brand Name : TRESIBA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 600 UNITS/3ML (200 UNITS/ML)

Packaging :

Approval Date :

Application Number : 203314

Regulatory Info :

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN DEGLUDEC

Brand Name : TRESIBA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 203314

Regulatory Info :

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN DEGLUDEC; LIRAGLUTIDE

Brand Name : XULTOPHY 100/3.6

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML;10.8MG/3ML (100 UNITS/ML;3.6MG/ML)

Packaging :

Approval Date :

Application Number : 208583

Regulatory Info :

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

insulin degludek

Brand Name : Tresiba

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 200 UNITS / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

insulin degludek

Brand Name : Tresiba

Dosage Form : SOLUTION FOR INJECTION IN CARTRIDGE

Dosage Strength : 100 UNITS / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

insulin degludek

Brand Name : Tresiba

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 100 UNITS / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Insulin Degludec 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : FLEXTOUCH SC 5 pens preriemp 3 ml 100 IU/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 100 E/ml

Packaging : Finish filled pen, flex touch

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 100 E/ml

Packaging : Sylinderampulle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 200 E/ml

Packaging : Finish filled pen, flex touch

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

degludec

Brand Name : Xultophy

Dosage Form : Injection fluid, resolution in the finished filled pen

Dosage Strength : 100 E/ml/3.6 mg/ml

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Insulin degludecum

Brand Name : Tresiba FlexTouch

Dosage Form : Inj L?s

Dosage Strength : 100U/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Insulin degludecum

Brand Name : Tresiba FlexTouch

Dosage Form : Inj Solution

Dosage Strength : 200U/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Insulin degludecum

Brand Name : Tresiba Penfill

Dosage Form : Inj Loose

Dosage Strength : 100U/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN DEGLUDEC

Brand Name : XULTOPHY

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 1X3ML/3X3ML/5X3ML

Approval Date :

Application Number : 2474875

Regulatory Info : Prescription

Registration Country : Canada

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN DEGLUDEC

Brand Name : TRESIBA

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 3ML / 5X3ML

Approval Date :

Application Number : 2467879

Regulatory Info : Schedule D

Registration Country : Canada

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN DEGLUDEC

Brand Name : TRESIBA

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 5X3ML

Approval Date :

Application Number : 2467860

Regulatory Info : Schedule D

Registration Country : Canada

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

INSULIN DEGLUDEC

Brand Name : TRESIBA

Dosage Form : SOLUTION

Dosage Strength : 200UNIT/ML

Packaging : 3ML/ 3X3ML

Approval Date :

Application Number : 2467887

Regulatory Info : Schedule D

Registration Country : Canada

blank